Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipoic acid for inflammation and antioxidant factors in multiple sclerosis
IRCT138812222602N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alpha-lipoic acid in multiple sclerosis (MS), sponsored by Iran University of Medical Sciences. Primary endpoints: Inflammation markers and Antioxidant factors. Started Sep 2010; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT138812222602N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138812222602N2.